We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+21.05%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.21B
AUM Growth
+$149M
Cap. Flow
-$69.1M
Cap. Flow %
-3.12%
Top 10 Hldgs %
77.25%
Holding
38
New
3
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
DERM
Dermira, Inc.
DERM
+$58.9M
2
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$24.8M
3
ZSAN
Zosano Pharma Corporation
ZSAN
+$23.1M
4
AGRX
Agile Therapeutics
AGRX
+$35.1K

Top Sells

Rank Stock Value
1
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
+$122M
2
FOLD
Amicus Therapeutics
FOLD
+$47M
3
WIFI
Boingo Wireless, Inc.
WIFI
+$7.48M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$57

Sector Composition

Rank Sector Weight
1 Healthcare 62.5%
2 Communication Services 14.94%
3 Technology 9.43%
4 Consumer Discretionary 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$566M 25.58%
9,854,255
– –
GRPN icon
2
Groupon
GRPN
$1.05B
$318M 14.4%
2,208,648
– –
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
$169M 7.65%
2,279,781
– –
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.74B
$129M 5.82%
10,650,000
– –
HPTX
5
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$109M 4.95%
2,384,221
– –
EPZM
6
DELISTED
Epizyme, Inc
EPZM
$96.7M 4.37%
5,149,740
– –
OPWR
7
DELISTED
OPOWER INC COM STK (DE)
OPWR
$91.1M 4.12%
8,997,290
– –
CVT
8
DELISTED
CVENT, INC.
CVT
$84M 3.8%
2,996,738
– –
ARDX icon
9
Ardelyx
ARDX
$1.24B
$73.6M 3.33%
5,621,199
– –
CBIO
10
Crescent Biopharma
CBIO
$595M
$71.3M 3.23%
85,751
– –
NVRO
11
DELISTED
NEVRO CORP.
NVRO
$65.7M 2.97%
1,369,899
– –
DERM
12
DELISTED
Dermira, Inc.
DERM
$53.8M 2.43%
+3,506,649
New +$58.9M
TRIV
13
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$41.4M 1.87%
3,945,191
– –
TRVN
14
DELISTED
Trevena, Inc.
TRVN
$31.4M 1.42%
7,699
– –
VTAE
15
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$30.6M 1.38%
2,613,199
– –
OREX
16
DELISTED
Orexigen Therapeutics, Inc.
OREX
$29M 1.31%
370,900
– –
TCON
17
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$26.5M 1.2%
+9,448
New +$24.8M
CRCM
18
DELISTED
CARE.COM, INC.
CRCM
$24.7M 1.12%
3,260,989
– –
LOXO
19
DELISTED
Loxo Oncology, Inc
LOXO
$22.3M 1.01%
1,792,207
– –
ZSAN
20
DELISTED
Zosano Pharma Corporation
ZSAN
$21.8M 0.99%
+3,084
New +$23.1M
HIVE
21
DELISTED
Aerohive Networks
HIVE
$21.7M 0.98%
4,861,455
– –
WIFI
22
DELISTED
Boingo Wireless, Inc.
WIFI
$18.8M 0.85%
2,496,312
-963,148
-28% -$7.48M
LXRX icon
23
Lexicon Pharmaceuticals
LXRX
$1.03B
$15.7M 0.71%
2,382,286
– –
GYRE icon
24
Gyre Therapeutics
GYRE
$654M
$13.6M 0.61%
5,799
– –
MM
25
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$11.9M 0.54%
8,224,752
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q1 2015 Portfolio in Review

As of Q1 2015, NEA Management Company held 38 positions worth $2.21B, up 7.2% from $2.06B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

NEA Management Company withdrew a net $69.1M in Q1 2015, closing 2 positions and reducing 2 holdings. Its most notable exit was PROSENSA HLDGS N V ORD SHS (NLD), an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 53% a quarter earlier, followed by Communication Services and Technology.

Against the trend, NEA Management Company opened a new position in Dermira, Inc. worth $53.8M.

  • NEA Management Company's largest Q1 2015 buy was Dermira, Inc.: 3,506,649 shares worth $53.8M.
  • NEA Management Company added most to Agile Therapeutics in Q1 2015, an estimated $35.1K increase.
  • NEA Management Company's biggest Q1 2015 reduction was Boingo Wireless, Inc., cutting an estimated $7.48M.
  • NEA Management Company fully exited PROSENSA HLDGS N V ORD SHS (NLD) in Q1 2015, selling an estimated $122M.
  • NEA Management Company's ten largest holdings make up 77% of its $2.21B portfolio in Q1 2015.
  • NEA Management Company opened 3 new positions and closed 2 in Q1 2015.
  • NEA Management Company's portfolio value rose 7.2% quarter-over-quarter to $2.21B.

Based on NEA Management Company's 13F filing for Q1 2015, filed 6 May 2015.